APA način citiranja

V, C., & M, B. (2020). Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to Date. Dove Medical Press.

Čikaški stil citiranja

V, Chau, i Bilusic M. Pembrolizumab in Combination With Axitinib As First-Line Treatment for Patients With Renal Cell Carcinoma (RCC): Evidence to Date. Dove Medical Press, 2020.

MLA način citiranja

V, Chau, i Bilusic M. Pembrolizumab in Combination With Axitinib As First-Line Treatment for Patients With Renal Cell Carcinoma (RCC): Evidence to Date. Dove Medical Press, 2020.